Total planned funding: $484,911,280
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $74,125,621 |
Nigeria | $73,379,437 |
South Africa | $59,663,185 |
Zambia | $48,313,838 |
Asia Regional Program | $38,875,709 |
Vietnam | $16,198,222 |
Burundi | $15,590,036 |
West Africa Region | $13,460,980 |
Zimbabwe | $13,399,089 |
Kenya | $12,296,799 |
India | $11,864,357 |
Haiti | $11,291,769 |
Dominican Republic | $7,801,779 |
Côte d'Ivoire | $7,702,618 |
Indonesia | $7,051,794 |
Ghana | $6,982,500 |
Malawi | $6,902,046 |
Ethiopia | $6,871,412 |
Botswana | $6,526,637 |
Tanzania | $6,480,431 |
enumerations.Philippines | $6,341,584 |
Democratic Republic of the Congo | $6,182,190 |
Eswatini | $4,327,687 |
South Sudan | $3,435,929 |
Lesotho | $3,392,229 |
Rwanda | $2,594,238 |
Caribbean Region | $2,525,420 |
Papua New Guinea | $2,486,306 |
Angola | $2,466,719 |
Uganda | $2,149,426 |
Cambodia | $2,025,000 |
Namibia | $1,497,275 |
Western Hemisphere Region | $709,018 |
Central Asia Region | $0 |
Organizational Types
NGO | $484,911,280 |
Program Areas
Care | $136,877,552 |
Treatment | $129,214,851 |
Prevention | $118,317,040 |
Testing | $54,290,626 |
Governance and Systems | $46,211,211 |
Budget Codes
HTXS: Treatment: Adult Treatment | $112,407,158 |
HKID: Care: Orphans and Vulnerable Children | $67,328,134 |
HVOP: Sexual Prevention: Other Sexual Prevention | $66,224,905 |
HVCT: Testing: HIV Testing and Counseling | $54,290,626 |
HBHC: Care: Adult Care and Support | $49,354,819 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $20,293,625 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,197,124 |
HVSI: Strategic Information | $17,003,467 |
OHSS: Health Systems Strengthening | $16,526,516 |
HLAB: Laboratory Infrastructure | $12,681,228 |
PDTX: Treatment: Pediatric Treatment | $11,725,579 |
PDCS: Care: Pediatric Care and Support | $10,331,198 |
HVTB: Care: TB/HIV | $9,863,401 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,281,912 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,525,361 |
HMIN: Biomedical Prevention: Injection Safety | $402,784 |
HMBL: Biomedical Prevention: Blood Safety | $391,329 |
Top Partner Programs
FHI 360:
$484,911,280
View countries